Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures

被引:137
作者
Wiegand, Irith
Geiss, Heinrich K.
Mack, Dietrich
Stuerenburg, Enno
Seifert, Harald
机构
[1] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany
[2] Univ Bonn, Dept Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Unit, D-5300 Bonn, Germany
[3] Heidelberg Univ, Sect Infectiol, Inst Hyg, Heidelberg, Germany
[4] Univ Coll Swansea, Sch Med, Swansea SA2 8PP, W Glam, Wales
[5] Univ Hamburg, Hosp Eppendorf, Inst Med Microbiol Virol & Hyg, Ctr Clin Pathol, D-20246 Hamburg, Germany
关键词
D O I
10.1128/JCM.01988-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Three commercially available microbiology identification and susceptibility testing systems were compared with regard to their ability to detect extended-spectrum P-lactamase (ESBL) production in Enterobacteriaceae, i.e., the Phoenix Automated Microbiology System (BD Diagnostic Systems, Sparks, MD), the VITEK 2 System (bioMerieux, Marcy l'Etoile, France), and the MicroScan WalkAway-96 System (Dade Behring, Inc., West Sacramento, CA), using routine testing panels. One hundred fifty putative ESBL producers were distributed blindly to three participating laboratories. Conventional phenotypic confirmatory tests such as the disk approximation method, the CLSI double-disk synergy test, and the Etest ESBL were also evaluated. Biochemical and molecular characterization of beta-lactamases performed at an independent laboratory was used as the reference method. One hundred forty-seven isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, Serratia marcescens, Proteus mirabilis, Proteus vulgaris, and Morganella morganii were investigated. Of these isolates, 85 were identified as ESBL producers by the reference method. The remaining isolates were identified as non-ESBL producers; they were either hyperproducers of their chromosomal AmpC, Koxy, or SHV enzymes or lacked any detectable P-lactamase activity. The system with the highest sensitivity for the detection of ESBLs was the Phoenix (99%), followed by the VITEK 2 (86%) and the MicroScan (84%); however, specificity was more variable, ranging from 52% (Phoenix) to 78% (VITEK 2). The performance of the semiautomated systems differed widely with the species investigated. The sensitivities of the conventional test methods ranged from 93 to 94%. The double-disk synergy test showed the highest specificity and positive predictive value among all test methods, i.e., 97% and 98%, respectively.
引用
收藏
页码:1167 / 1174
页数:8
相关论文
共 29 条
  • [1] Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations
    Andes, D
    Craig, WA
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 : 10 - 17
  • [2] On bridging the gap
    Bonner, LT
    [J]. ACADEMIC PSYCHIATRY, 2003, 27 (01) : 29 - 30
  • [3] *CLIN LAB STAND I, 2006, 7100S16 CLSI
  • [4] Evaluation of Oxoid combination discs for detection of extended-spectrum β-lactamases
    De Gheldre, Y
    Avesani, V
    Berhin, C
    Delmée, M
    Glupczynski, Y
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) : 591 - 597
  • [5] PROPERTIES OF PLASMIDS RESPONSIBLE FOR PRODUCTION OF EXTENDED-SPECTRUM BETA-LACTAMASES
    JACOBY, GA
    SUTTON, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) : 164 - 169
  • [6] JARLIER V, 1988, REV INFECT DIS, V10, P867
  • [7] EVOLUTION OF PLASMID-CODED RESISTANCE TO BROAD-SPECTRUM CEPHALOSPORINS
    KLIEBE, C
    NIES, BA
    MEYER, JF
    TOLXDORFFNEUTZLING, RM
    WIEDEMANN, B
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) : 302 - 307
  • [8] A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg
    Koeck, JL
    Arlet, G
    Philippon, A
    Basmaciogullari, S
    Thien, HV
    Buisson, Y
    Cavallo, JD
    [J]. FEMS MICROBIOLOGY LETTERS, 1997, 152 (02) : 255 - 260
  • [9] Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum β-lactamases isolated in Japan
    Komatsu, M
    Aihara, M
    Shimakawa, K
    Iwasaki, M
    Nagasaka, Y
    Fukuda, S
    Matsuo, S
    Iwatani, Y
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 46 (02) : 125 - 130
  • [10] Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.
    Leverstein-van Hall, MA
    Fluit, AC
    Paauw, A
    Box, ATA
    Brisse, S
    Verhoef, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3703 - 3711